PITTSBURGH, Aug. 22, 2013 -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company has received approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug ...
The U.S. Food and Drug Administration (FDA) has reviewed new data that indicate Budeprion XL 300 mg (bupropion hydrochloride extended-release tablets), manufactured by Impax Laboratories, Inc., and ...
WASHINGTON — The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax ...
(HealthDay)—People taking the antidepressant Wellbutrin now have one less option for a generic version of the drug. In October, the U.S. Food and Drug Administration recommended that generic ...
October 4, 2012 — The antidepressant Budeprion XL 300 mg, one of the generic formulations of extended-release bupropion hydrochloride, is not therapeutically equivalent to Wellbutrin XL 300 mg, the ...
AUSTIN, Texas, Oct. 9, 2012 /PRNewswire/ -- Edgemont Pharmaceuticals, LLC, a neuroscience-focused company, today announced that Forfivo™ XL (bupropion hydrochloride extended-release tablets) is now ...
Research Triangle Park, NC (August 28, 2003) -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Wellbutrin XL™ (bupropion hydrochloride extended-release tablets ...
Medscape recently surveyed readers to examine their experiences with use of generic products. While the majority voiced support for use of generics in general, noting that they were typically safe and ...
The lowest dose of Wellbutrin XL is 150 mg. This is the recommended Wellbutrin XL dosage to start with. However, , most people move up to 300 mg Wellbutrin tablet after a few days or a week, depending ...
The US Food and Drug Administration (FDA) is looking to sponsor its own bioequivalency studies on more generic versions of a popular antidepressant in the wake of the agency's October 2012 finding ...
The FDA has reviewed new data that indicate Budeprion XL 300mg (bupropion HCl extended-release tablets; Impax Laboratories), marketed by Teva, is not therapeutically equivalent to GlaxoSmithKline‘s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results